What does Obsidian Therapeutics, Inc. do?
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory…
What is Obsidian Therapeutics, Inc.'s P/E and P/B ratio?
Obsidian Therapeutics, Inc. has a P/E ratio of -8.6 and a P/B ratio of -3.12.
What is Obsidian Therapeutics, Inc.'s debt-to-equity ratio?
Obsidian Therapeutics, Inc. has a debt-to-equity ratio of 0.10.
How much does Obsidian Therapeutics, Inc. owe compared with what it owns?
Obsidian Therapeutics, Inc. owes $4.94 for every $1 it owns (balance sheet Mar 2026), which means it owes more than it owns.
What is Obsidian Therapeutics, Inc.'s Positivity rank?
Obsidian Therapeutics, Inc. is ranked #6,423 of 6,774 companies globally and #3,687 of 4,000 in United States on PositoAI, with a Positivity Score of -19,226.
Does Obsidian Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Obsidian Therapeutics, Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 2/10 points): Change of auditor (8-K Item 4.01).
Where can I read the latest news about Obsidian Therapeutics, Inc.?
Recent headlines about Obsidian Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Obsidian Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Obsidian Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.